INFeD
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.infed.comRevenue
<$5 MillionIndustry
About INFeD
AbbVie offers INFeD, an FDA-approved low-molecular-weight iron dextran injection designed for the treatment of iron deficiency and iron deficiency anemia in patients aged 4 months and older who cannot tolerate or have not responded satisfactorily to oral iron. The product is intended for healthcare professionals and is widely covered by most insurance plans. INFeD requires careful administration due to the risk of anaphylactic-type reactions, necessitating monitoring and resuscitation equipment during its use. The company emphasizes the importance of clinical and laboratory investigations to confirm iron deficiency before administration.Explore more
SIC Code 28,283NAICS Code 32,325Show more
INFeD Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
INFeD Tech Stack
A closer look at the technologies used by INFeD
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding INFeD
Sign Up For FreeTo access detailed company insights
AbbVie offers INFeD, an FDA-approved low-molecular-weight iron dextran injection designed for the treatment of iron deficiency and iron deficiency anemia in patients aged 4 months and older who cannot tolerate or have not responded satisfactorily to oral iron. The product is intended for healthcare professionals and is widely covered by most insura... Read More
